Jieduquyuzishen Prescription Attenuates Renal Fibrosis in MRL/lpr Mice via Inhibiting EMT and TGF-β1/Smad2/3 Pathway

Jieduquyuziyin prescription (JP) has been used to treat lupus nephritis (LN) and its effectiveness in the treatment of LN has been clinically proven, but the underlying mechanisms have yet to be completely understood. This aim of this study was to clarify the efficacy of JP on the epithelial-mesench...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Shan, Ji, Lina, Fan, Xuemin, Fang, Sijia, Bao, Jie, Yuan, Xiao, Fan, Yongsheng, Xie, Guanqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113882/
https://www.ncbi.nlm.nih.gov/pubmed/35591863
http://dx.doi.org/10.1155/2022/4987323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113882/
https://www.ncbi.nlm.nih.gov/pubmed/35591863
http://dx.doi.org/10.1155/2022/4987323

Ejemplares similares